Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion type Assertion NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_head.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion description "[Furthermore, the relative expression of miR-21, miR-126, miR-155, miR-199a and miR-335 was closely associated with clinicopathologic features of breast cancer (P < 0.05), such as histological tumor grades and sex hormone receptor expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_provenance.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion evidence source_evidence_literature NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_provenance.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion SIO_000772 20801493 NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_provenance.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion wasDerivedFrom befree-2016 NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_provenance.
- NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_assertion wasGeneratedBy ECO_0000203 NP835568.RAaCxE-d-O3UsTii4Fdh8m992fEKgU08dfsx9sLr-LyJA130_provenance.